The survival time of patients with lung cancer lung infection can not be generalized, and the difference between different patients is relatively large. At present, the five-year survival rate is commonly used to assess the survival of patients, and generally the five-year survival rate of patients with stage I is about 80%, and that of patients with stage IV is only about 10%.
The survival time of patients with lung cancer lung infection is related to the clinical stage, pathological type and severity of lung infection. If the patient has early stage I lung cancer and the lung infection is not serious, and effective anti-infection treatment is given and then radical surgery is taken to remove the lung cancer, most of the patients can achieve a curative effect, and the patient can survive for five years or for a long time.
If the patient’s lung cancer is in the advanced stage and the lung infection is more serious, the serious infection prevents the patient from taking radiotherapy, chemotherapy, targeting and other active anti-cancer treatment measures in time, thus leading to the rapid development of lung cancer lesions, and the patient may only have a few months of survival time.
Lung cancer patients should seek medical treatment in time after developing lung infection.